Benzodiazepines and z-drugs: Quality prescribing - a guide for improvement
| A&A | Ayrshire and Arran Health Board |
| ADR | Adverse drug reaction |
| BAP | British Association for Psychopharmacology |
| B-Z | Benzodiazepine and/or z-drug |
| B12 | Vitamin B12 (cobalamin) |
| CBT | Cognitive behavioural therapy |
| cCBT | Computerised Cognitive Behavioural Therapy |
| CLW | Community Link Worker |
| DDD | Average defined daily |
| D&G | Dumfries and Galloway Health Board |
| FBC | Full blood count |
| FV | Forth Valley Health Board |
| GAD | Generalized anxiety disorder |
| GAD-7 | Generalised Anxiety Disorder questionnaire |
| GGC | Greater Glasgow and Clyde Health Board |
| GP | General practitioner |
| HSCP | Health and Social Care Partnership |
| LFTs | Liver function tests |
| MAT | Medication Assisted Treatment |
| MDI | Metered dose inhaler |
| MR | Modified Release |
| NHS | National Health Service |
| NICE | National Institute for Clinical Excellence |
| NNH | Numbers needed to harm |
| NNT | Numbers needed to treat |
| NTI | National Therapeutic Indicator |
| OTC | Over the counter |
| PHQ-9 | Patient Health Questionnaire |
| PROMs | Patient Reported Outcomes Measures |
| PTSD | Post-traumatic stress disorder |
| QOF | Quality and Outcomes Framework |
| SSRI | Selective serotonin re-uptake inhibitor |
| STU | Scottish Therapeutics Utility |
| TFT | Thyroid function test |
| U&Es | Urea and electrolytes |
| WI | Western Isles Health Board |